In order to understand the failure of avasimibe treatment to prevent breast cancer in SV40 C3(1) TAg mice, we tested whether avasimibe hit its target and inhibited ACAT1 and ACAT2 expression. The gene discussed is ACAT2; the disease is breast carcinoma.